Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression

​ Conditions: Glioblastoma

Interventions: Drug: Sintilimab; Drug: Bevacizumab; Radiation: Postoperative Radiotherapy; Drug: Temozolomide

Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University

Recruiting Conditions: Glioblastoma
Interventions: Drug: Sintilimab; Drug: Bevacizumab; Radiation: Postoperative Radiotherapy; Drug: Temozolomide
Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting